Proteo Biotech AG
Proteo Biotech AG, researches, develops and markets nature identical compounds for biological and medical research as well as for use as pharmaceuticals. The Company’s focus is on the development of anti-inflammatory treatments for rare diseases with significant unmet needs. Proteo is engaged in the development of pharmaceuticals based on the body’s own tools and weapons to fight inflammatory diseases.
|API OR DRUG SUBSTANCE SERVICES|